Seeking Alpha

AstraZeneca beats by $0.22, beats on revenues

  • AstraZeneca (NYSE:AZN) Q2 core EPS of $1.30, beats by $0.22.
  • Core operating profit decline 1% to $2.03B.
  • Revenue +4% to $6.45B, topping consensus of $6.24B.
  • The company revised FY14 Core EPS guidance to decrease in low double digits at CER, revenue in line at CER from FY13.
  • The company declared interim dividend of $0.90.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector